最新的帖子

十二月 28, 2020

Particles in Injectable Drugs

A parenteral drug product contaminated by particles is a potential health threat. In the bloodstream, particles can cause serious issues, such as capillary occlusion and immunogenic responses. In most cases, the observation of particles in a drug product leads to a recall.
Lynn Yao

Lynn Yao

Manager, Scientific Affairs, CN

以前的博客
Particle Analysis

六月 11, 2019

Particulate Challenges

Fran DeGrazio

Fran DeGrazio

V.P. Technical Customer Service & Scientific Affairs

Leo Posner of Johnson & Johnson presenting at the PDA Combo Workshop

四月 03, 2019

The Challenges of Combination Products

Fran DeGrazio

Fran DeGrazio

VP, Technical Services and Scientific Affairs

Compatibility Issues Chart

三月 07, 2019

Simplify the Journey™ - Integrated Solutions for Particles

Doug Hostetler

Doug Hostetler

Sr Manager, Integrated Solutions, Lab

Particle Testing

三月 01, 2019

Achieving ″Zero″ Defects for Visible Particles in Injectables

Olga Laskina

Olga Laskina

Sr. Technical Account Specialist, TCS, NA

Leur Lock Syringes

二月 25, 2019

Particles in Intravitreal Injections - Part II

Susan Dounce

Susan Dounce

Principal SME, PFS CZ, TCS

Load more